What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Myocardial infarction
Markku S. Nieminen focuses on Internal medicine, Cardiology, Heart failure, Surgery and Myocardial infarction.
His research related to Losartan, Atenolol, Heart disease, Blood pressure and Risk factor might be considered part of Internal medicine.
His Cardiology research is multidisciplinary, incorporating elements of Stroke and Left ventricular hypertrophy.
His research integrates issues of Decompensation, Cardiogenic shock and Intensive care medicine in his study of Heart failure.
The study incorporates disciplines such as Diabetes mellitus, Placebo and Atorvastatin in addition to Surgery.
His research investigates the link between Myocardial infarction and topics such as Immunology that cross with problems in Coronary heart disease.
His most cited work include:
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. (4860 citations)
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial (3235 citations)
- Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial (2328 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Cardiology, Heart failure, Left ventricular hypertrophy and Myocardial infarction.
Internal medicine is closely attributed to Endocrinology in his study.
In his work, Stroke is strongly intertwined with Atenolol, which is a subfield of Cardiology.
His research in Heart failure intersects with topics in Hemodynamics, Inotrope and Intensive care medicine.
He has included themes like Albuminuria and Risk factor in his Left ventricular hypertrophy study.
The concepts of his Myocardial infarction study are interwoven with issues in Framingham Risk Score, Surgery and Hazard ratio.
He most often published in these fields:
- Internal medicine (78.18%)
- Cardiology (60.56%)
- Heart failure (22.86%)
What were the highlights of his more recent work (between 2013-2020)?
- Internal medicine (78.18%)
- Cardiology (60.56%)
- Myocardial infarction (19.55%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Cardiology, Myocardial infarction, Heart failure and Acute coronary syndrome.
His Internal medicine study frequently draws parallels with other fields, such as Endocrinology.
The Cardiology study combines topics in areas such as Epidemiology and Left ventricular hypertrophy, Blood pressure.
Markku S. Nieminen interconnects Cardiomyopathy, Framingham Risk Score and Cohort study in the investigation of issues within Myocardial infarction.
His Heart failure research integrates issues from Clinical trial and Intensive care medicine.
His studies deal with areas such as Percutaneous coronary intervention, Diabetes mellitus, Cardiogenic shock, Disease and Cohort as well as Acute coronary syndrome.
Between 2013 and 2020, his most popular works were:
- A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease (1174 citations)
- The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study (455 citations)
- A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease (355 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Cardiology
Markku S. Nieminen spends much of his time researching Internal medicine, Cardiology, Coronary artery disease, Myocardial infarction and Heart failure.
As a part of the same scientific family, Markku S. Nieminen mostly works in the field of Internal medicine, focusing on Endocrinology and, on occasion, Inflammation.
His Cardiology study combines topics in areas such as Proportional hazards model, Epidemiology and Confidence interval.
His Coronary artery disease research is multidisciplinary, relying on both Body mass index, Pathology, Ldl cholesterol, Surgery and Gastroenterology.
His Myocardial infarction research includes elements of Disease and Population study.
His Heart failure study which covers Intensive care medicine that intersects with Levosimendan, Remote patient monitoring, Transplantation and Cardiotonic Agents.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
